BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 26862065)

  • 1. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.
    Bleckmann A; Conradi LC; Menck K; Schmick NA; Schubert A; Rietkötter E; Arackal J; Middel P; Schambony A; Liersch T; Homayounfar K; Beißbarth T; Klemm F; Binder C; Pukrop T
    Clin Exp Metastasis; 2016 Apr; 33(4):309-23. PubMed ID: 26862065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.
    Klemm F; Bleckmann A; Siam L; Chuang HN; Rietkötter E; Behme D; Schulz M; Schaffrinski M; Schindler S; Trümper L; Kramer F; Beissbarth T; Stadelmann C; Binder C; Pukrop T
    Carcinogenesis; 2011 Mar; 32(3):434-42. PubMed ID: 21173432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
    Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
    Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression.
    Roarty K; Pfefferle AD; Creighton CJ; Perou CM; Rosen JM
    Oncogene; 2017 Oct; 36(43):5958-5968. PubMed ID: 28650466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.
    Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):243-54. PubMed ID: 25209439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
    Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
    World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
    Hou MF; Chen PM; Chu PY
    BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype-specific alterations of the Wnt signaling pathway in breast cancer: clinical and prognostic significance.
    Mukherjee N; Bhattacharya N; Alam N; Roy A; Roychoudhury S; Panda CK
    Cancer Sci; 2012 Feb; 103(2):210-20. PubMed ID: 22026417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/β-catenin signaling pathway.
    Fang Y; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    Cancer Biomark; 2018; 23(3):405-418. PubMed ID: 30223390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer.
    Kimbung S; Johansson I; Danielsson A; Veerla S; Egyhazi Brage S; Frostvik Stolt M; Skoog L; Carlsson L; Einbeigi Z; Lidbrink E; Linderholm B; Loman N; Malmström PO; Söderberg M; Walz TM; Fernö M; Hatschek T; Hedenfalk I;
    Clin Cancer Res; 2016 Jan; 22(1):146-57. PubMed ID: 26276891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis.
    Loehberg CR; Almstedt K; Jud SM; Haeberle L; Fasching PA; Hack CC; Lux MP; Thiel FC; Schrauder MG; Brunner M; Bayer CM; Hein A; Heusinger K; Heimrich J; Bani MR; Renner SP; Hartmann A; Beckmann MW; Wachter DL
    Breast Cancer Res Treat; 2013 Apr; 138(3):899-908. PubMed ID: 23479421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.
    Cui J; Xi H; Cai A; Bian S; Wei B; Chen L
    Int J Mol Med; 2014 Jul; 34(1):197-204. PubMed ID: 24788044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer.
    Rasmussen NR; Wright TM; Brooks SA; Hacker KE; Debebe Z; Sendor AB; Walker MP; Major MB; Green J; Wahl GM; Rathmell WK
    J Biol Chem; 2013 Sep; 288(36):26301-26310. PubMed ID: 23893409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
    St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
    Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness.
    Tsujikawa H; Masugi Y; Yamazaki K; Itano O; Kitagawa Y; Sakamoto M
    Hum Pathol; 2016 Apr; 50():24-33. PubMed ID: 26997435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic biomarkers for metastatic colorectal cancer].
    Neumann JH
    Pathologe; 2016 Nov; 37(Suppl 2):180-185. PubMed ID: 27638531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the expression of prognostic biomarkers between primary tumor and axillary lymph node metastases in breast cancer.
    Zhao S; Xu L; Liu W; Lv C; Zhang K; Gao H; Wang J; Ma R
    Int J Clin Exp Pathol; 2015; 8(5):5744-8. PubMed ID: 26191291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
    Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y
    Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
    Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
    Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.